Preoperative serum hyaluronic acid level as a prognostic factor in patients undergoing hepatic resection for hepatocellular carcinoma

British Journal of Surgery

Volumn 101, Issue 3, 2014, Pages 269-276

  Mima, K ^a   Beppu, T ^a,b   Ishiko, T ^a   Chikamoto, A ^a   Nakagawa, S ^a   Hayashi, H ^a   Watanabe, M ^a   Sakamaki, K ^c   Baba, H ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b KUMAMOTO UNIVERSITY HOSPITAL   (Japan)

^c YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; HYALURONIC ACID;

ADULT; AGED; ARTICLE; BLOOD; DISEASE FREE SURVIVAL; EVALUATION STUDY; FEMALE; HUMAN; LIVER CELL CARCINOMA; LIVER RESECTION; LIVER TUMOR; MALE; METABOLISM; METHODOLOGY; MIDDLE AGED; MORTALITY; PREOPERATIVE CARE; PROGNOSIS; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY;

ADULT; AGED; BIOLOGICAL MARKERS; CARCINOMA, HEPATOCELLULAR; DISEASE-FREE SURVIVAL; FEMALE; HEPATECTOMY; HUMANS; HYALURONIC ACID; LIVER NEOPLASMS; MALE; MIDDLE AGED; PREOPERATIVE CARE; PROGNOSIS; RETROSPECTIVE STUDIES; ROC CURVE;

EID: 84893703850     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.9343     Document Type: Article

References (25)

1. El-Serag HB,. Hepatocellular carcinoma. N Engl J Med 2011; 365: 1118-1127.
2. Lim KC, Chow PK, Allen JC, Siddiqui FJ, Chan ES, Tan SB,. Systematic review of outcomes of liver resection for early hepatocellular carcinoma within the Milan criteria. Br J Surg 2012; 99: 1622-1629.
3. Thelen A, Benckert C, Tautenhahn HM, Hau HM, Bartels M, Linnemann J, et al., Liver resection for hepatocellular carcinoma in patients without cirrhosis. Br J Surg 2013; 100: 130-137.
4. Toole BP,. Hyaluronan: from extracellular glue to pericellular cue. Nat Rev Cancer 2004; 4: 528-539.
5. Frebourg T, Delpech B, Bercoff E, Senant J, Bertrand P, Deugnier Y, et al., Serum hyaluronate in liver diseases: study by enzymoimmunological assay. Hepatology 1986; 6: 392-395.
6. Parés A, Deulofeu R, Giménez A, Caballería L, Bruguera M, Caballería J, et al., Serum hyaluronate reflects hepatic fibrogenesis in alcoholic liver disease and is useful as a marker of fibrosis. Hepatology 1996; 24: 1399-1403.
7. Toole BP, Slomiany MG,. Hyaluronan: a constitutive regulator of chemoresistance and malignancy in cancer cells. Semin Cancer Biol 2008; 18: 244-250.
8. Kosaki R, Watanabe K, Yamaguchi Y,. Overproduction of hyaluronan by expression of the hyaluronan synthase Has2 enhances anchorage-independent growth and tumorigenicity. Cancer Res 1999; 59: 1141-1145.
9. Simpson MA, Wilson CM, McCarthy JB,. Inhibition of prostate tumor cell hyaluronan synthesis impairs subcutaneous growth and vascularization in immunocompromised mice. Am J Pathol 2002; 161: 849-857.
10. Mima K, Okabe H, Ishimoto T, Hayashi H, Nakagawa S, Kuroki H, et al., CD44s regulates the TGF-β-mediated mesenchymal phenotype and is associated with poor prognosis in patients with hepatocellular carcinoma. Cancer Res 2012; 72: 3414-3423.
11. Yoshida M, Shiraishi S, Sakaguchi F, Utsunomiya D, Tashiro K, Tomiguchi S, et al., Fused 99 m-Tc-GSA SPECT/CT imaging for the preoperative evaluation of postoperative liver function: can the liver uptake index predict postoperative hepatic functional reserve? Jpn J Radiol 2012; 30: 255-262.
12. Beppu T, Ishiko T, Chikamoto A, Komori H, Masuda T, Hayashi H, et al., Liver hanging maneuver decreases blood loss and operative time in a right-side hepatectomy. Hepatogastroenterology 2012; 59: 542-545.
13. Strasberg SM,. Nomenclature of hepatic anatomy and resections: a review of the Brisbane 2000 system. J Hepatobiliary Pancreat Surg 2005; 12: 351-355.
14. Liver Cancer Study Group of Japan. The General Rules for the Clinical and Pathological Study of Primary Liver Cancer (5th edn, revised version). Kanehara: Tokyo, 2009.
15. Minagawa M, Ikai I, Matsuyama Y, Yamaoka Y, Makuuchi M,. Staging of hepatocellular carcinoma: assessment of the Japanese TNM and AJCC/UICC TNM systems in a cohort of 13 772 patients in Japan. Ann Surg 2007; 245: 909-922.
16. Vauthey JN, Lauwers GY, Esnaola NF, Do KA, Belghiti J, Mirza N, et al., Simplified staging for hepatocellular carcinoma. J Clin Oncol 2002; 20: 1527-1536.
17. Dindo D, Demartines N, Clavien PA,. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 2004; 240: 205-213.
18. Clavien PA, Barkun J, De Oliveira ML, Vauthey JN, Dindo D, Schulick RD, et al., The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg 2009; 250: 187-196.
19. Heagerty PJ, Zheng Y,. Survival model predictive accuracy and ROC curves. Biometrics 2005; 61: 92-105.
20. Llovet JM, Schwartz M, Mazzaferro V,. Resection and liver transplantation for hepatocellular carcinoma. Semin Liver Dis 2005; 25: 181-200.
21. Engelman JA,. Targeting PI3K signalling in cancer: opportunities, challenges and limitations. Nat Rev Cancer 2009; 9: 550-562.
22. Sohara Y, Ishiguro N, Machida K, Kurata H, Thant AA, Senga T, et al., Hyaluronan activates cell motility of v-Src-transformed cells via Ras-mitogen-activated protein kinase and phosphoinositide 3-kinase-Akt in a tumor-specific manner. Mol Biol Cell 2001; 12: 1859-1868.
23. Ghatak S, Hascall VC, Markwald RR, Misra S,. Stromal hyaluronan interaction with epithelial CD44 variants promotes prostate cancer invasiveness by augmenting expression and function of hepatocyte growth factor and androgen receptor. J Biol Chem 2010; 285: 19 821-19 832.
24. Kessenbrock K, Plaks V, Werb Z,. Matrix metalloproteinases: regulators of the tumor microenvironment. Cell 2010; 141: 52-67.
25. Yu Q, Stamenkovic I,. Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis. Genes Dev 2000; 14: 163-176.